Skip to content
Interius
  • Platform
    • Overview
    • Publications and Presentations
  • Pipeline
    • Overview
    • Clinical Trials
  • About Us
  • Careers
  • News
  • Contact
Interius
Interius
  • Platform
    • Overview
    • Publications and Presentations
  • Pipeline
    • Overview
    • Clinical Trials
  • About Us
  • Careers
  • News
  • Contact
Interius

News

Read the latest news about our company.
To learn more about our research, visit our publications page.

See our publications
November 25, 2024 | Media Coverage
BiotechTV: Philadelphia based Interius BioTherapeutics recently dosed the first patient for its in vivo CAR therapy that edits T and NK cells in the body so they target CD20 positive cells in B-cell malignancies
October 31, 2024 | Media Coverage
Philadelphia Business Journal: University of Pennsylvania gene therapy spinout Interius BioTherapeutics doses patient, achieves CAR therapy first
October 28, 2024 | Media Coverage
pharmaphorum: Viva in vivo: The next generation of cell therapy is fast approaching
October 23, 2024 | Press Release
Interius BioTherapeutics Doses First Patient with in vivo Chimeric Antigen Receptor (CAR) Gene Therapy for B-cell Malignancies
October 23, 2024 | Media Coverage
Inside Precision Medicine: First Patient Dosed with In Vivo Gene Therapy for CAR T
October 9, 2024 | Media Coverage
XTalks: A Unique Approach to in vivo CAR T Therapy and New Advancements in the Field
12345...»

Interius

  • Platform
    • Overview
    • Publications and Presentations
  • Pipeline
    • Overview
    • Clinical Trials
  • About Us
  • Careers
  • News
  • Contact
  • Platform
    • Overview
    • Publications and Presentations
  • Pipeline
    • Overview
    • Clinical Trials
  • About Us
  • Careers
  • News
  • Contact

Interius Logo

Science

  • Platform
  • Pipeline
  • INT2104
  • INT2106
  • Publications
  • Clinical Trials

Company

  • About Us
  • Leadership
  • Board of Directors
  • Careers
  • Contact
  • News

Copyright © 2025 Interius BioTherapeutics, Inc. All Rights Reserved.
Interius® is a registered trademark of Interius BioTherapeutics, Inc.

  • Accessibility
  • Cookies Notice
  • Privacy Notice
  • Terms of Use